Showing 1 to 12 of 22 results


Wearable Tech Revolutionizes Clinical Trials
Medical-grade wearables are increasingly used in later-stage clinical trials, providing continuous data, improving safety detection, and streamlining trial design, driven by FDA support and patient demand for remote participation.
Wearable Tech Revolutionizes Clinical Trials
Medical-grade wearables are increasingly used in later-stage clinical trials, providing continuous data, improving safety detection, and streamlining trial design, driven by FDA support and patient demand for remote participation.
Progress
48% Bias Score


BSX Earnings: 60% Historical Probability of Positive Post-Earnings Returns
Boston Scientific (BSX) is set to release earnings on July 23, 2025; its stock has shown a positive one-day return after earnings 60% of the time over the past five years, with a median gain of 3.2%, suggesting a potential trading strategy, although performance is not guaranteed.
BSX Earnings: 60% Historical Probability of Positive Post-Earnings Returns
Boston Scientific (BSX) is set to release earnings on July 23, 2025; its stock has shown a positive one-day return after earnings 60% of the time over the past five years, with a median gain of 3.2%, suggesting a potential trading strategy, although performance is not guaranteed.
Progress
48% Bias Score


China Limits EU Medical Device Purchases in Retaliation
China announced it will limit government purchases of EU medical devices exceeding 45 million yuan (roughly 5.3 million euros) in response to the EU's restrictions on Chinese firms in public procurement, escalating trade tensions and raising concerns about market access and patient care.
China Limits EU Medical Device Purchases in Retaliation
China announced it will limit government purchases of EU medical devices exceeding 45 million yuan (roughly 5.3 million euros) in response to the EU's restrictions on Chinese firms in public procurement, escalating trade tensions and raising concerns about market access and patient care.
Progress
32% Bias Score


China Retaliates Against EU, Restricting Medical Device Procurement
China implemented immediate restrictions on EU medical device procurement exceeding $6.28 million, retaliating against similar EU measures; this affects surgical instruments, MRI equipment, and other devices, impacting EU businesses but exempting projects solely reliant on EU imports.
China Retaliates Against EU, Restricting Medical Device Procurement
China implemented immediate restrictions on EU medical device procurement exceeding $6.28 million, retaliating against similar EU measures; this affects surgical instruments, MRI equipment, and other devices, impacting EU businesses but exempting projects solely reliant on EU imports.
Progress
44% Bias Score


EU Blocks Chinese Firms from Medical Device Procurement Contracts
The European Union is excluding Chinese companies from bidding on public procurement contracts for medical devices worth over €5 million for five years using its International Procurement Instrument (IPI), prompting strong opposition from China which views this as protectionism and a threat to fair ...
EU Blocks Chinese Firms from Medical Device Procurement Contracts
The European Union is excluding Chinese companies from bidding on public procurement contracts for medical devices worth over €5 million for five years using its International Procurement Instrument (IPI), prompting strong opposition from China which views this as protectionism and a threat to fair ...
Progress
52% Bias Score


Medical Device Tariffs to Increase Healthcare Costs
President Trump's tariffs on medical devices, with approximately 40% manufactured overseas (primarily in Mexico and Europe), are expected to increase costs by $10 million to $25 million annually for some health systems, potentially causing shortages of critical medical devices and impacting patient ...
Medical Device Tariffs to Increase Healthcare Costs
President Trump's tariffs on medical devices, with approximately 40% manufactured overseas (primarily in Mexico and Europe), are expected to increase costs by $10 million to $25 million annually for some health systems, potentially causing shortages of critical medical devices and impacting patient ...
Progress
48% Bias Score

FDA Issues Safety Warnings for Boston Scientific Heart Devices
The FDA issued safety warnings for two Boston Scientific heart devices—the Endotak Reliance defibrillator, linked to 386 serious injuries and 16 deaths, and the Watchman device, linked to 120 serious injuries and 17 deaths—prompting concerns about device safety and the company's financial standing.

FDA Issues Safety Warnings for Boston Scientific Heart Devices
The FDA issued safety warnings for two Boston Scientific heart devices—the Endotak Reliance defibrillator, linked to 386 serious injuries and 16 deaths, and the Watchman device, linked to 120 serious injuries and 17 deaths—prompting concerns about device safety and the company's financial standing.
Progress
24% Bias Score

Portable Ultrasound Devices: Addressing Healthcare Disparities in Tanzania
A Tanzanian doctoral student in Chengdu, China, is developing affordable portable ultrasound devices to improve healthcare access in his home country, addressing challenges in early disease detection and impacting women's health.

Portable Ultrasound Devices: Addressing Healthcare Disparities in Tanzania
A Tanzanian doctoral student in Chengdu, China, is developing affordable portable ultrasound devices to improve healthcare access in his home country, addressing challenges in early disease detection and impacting women's health.
Progress
52% Bias Score

China Retaliates Against EU Medical Device Restrictions
China implemented countermeasures against EU medical device imports exceeding $6.3 million in government procurement programs, responding to the EU's prior restrictions on Chinese companies; the move affects surgical instruments, MRI equipment, and other devices, with exceptions for projects where o...

China Retaliates Against EU Medical Device Restrictions
China implemented countermeasures against EU medical device imports exceeding $6.3 million in government procurement programs, responding to the EU's prior restrictions on Chinese companies; the move affects surgical instruments, MRI equipment, and other devices, with exceptions for projects where o...
Progress
44% Bias Score

EU Counters China's Discriminatory Medical Device Trade Practices
The European Commission imposed restrictions on Chinese companies bidding for EU medical device contracts over €5 million, limiting Chinese inputs to 50%, in response to China's discriminatory practices against EU medical device manufacturers, marking the first use of the EU's International Procurem...

EU Counters China's Discriminatory Medical Device Trade Practices
The European Commission imposed restrictions on Chinese companies bidding for EU medical device contracts over €5 million, limiting Chinese inputs to 50%, in response to China's discriminatory practices against EU medical device manufacturers, marking the first use of the EU's International Procurem...
Progress
44% Bias Score

EU bars Chinese firms from medical device contracts
The EU blocked Chinese firms from bidding on public procurement contracts for medical devices exceeding €5 million for five years, prompting criticism from the Chinese Chamber of Commerce in the EU, which denounced it as protectionist and contradictory to the EU's proclaimed principles of open marke...

EU bars Chinese firms from medical device contracts
The EU blocked Chinese firms from bidding on public procurement contracts for medical devices exceeding €5 million for five years, prompting criticism from the Chinese Chamber of Commerce in the EU, which denounced it as protectionist and contradictory to the EU's proclaimed principles of open marke...
Progress
52% Bias Score

Funding Stalls Lifesaving Infant Dialysis Device
A new haemodialysis device for infants, Nidus, developed in Newcastle over 20 years and successfully trialled, is stalled due to lack of funding and regulatory pathways for "orphan" devices, leaving babies needing dialysis at risk.

Funding Stalls Lifesaving Infant Dialysis Device
A new haemodialysis device for infants, Nidus, developed in Newcastle over 20 years and successfully trialled, is stalled due to lack of funding and regulatory pathways for "orphan" devices, leaving babies needing dialysis at risk.
Progress
40% Bias Score
Showing 1 to 12 of 22 results